Articles On Nanollose (ASX:NC6)

A recent research reveals which biotech segments VCs are ploughing billions of dollars into We list the ASX companies that are operating within those thematics We also list the best and worst ASX biotech performers over the past week and m...

The ASX 200 and XEC small cap indices rise Attention turns to Tuesday’s date with RBA destiny Celsius Resources is hot   The ASX 200 and the Emerging Markets (XEC) indices are both trading higher on Monday up about 1.2%, ahead of tomorrow...

Nanollose will launch a Lee Mathews designed garment made from its eco-friendly Nullarbor lyocell fibre at a leading international forum for sustainability in fashion this month. Australia-based biomaterial technology company Nanollose (AS...

Nanollose has signed a key deal with a major global fashion retailer as its eco-friendly microbial cellulose-based technology continues to attract world interest. Australian-based biomaterial technology company Nanollose (ASX: NC6) has anno...

Nanollose (NC6) signs a memorandum of understanding (MoU) with Industria de Diseño Textil (INDITEX), one of the world’s largest fashion retailers Under the non-exclusive MoU, Nanollose will initially give free samples of the company’s flag...

Nanollose has signed another key collaboration agreement as interest continues to grow in its eco-friendly microbial cellulose-based technology. Australian-based biomaterial technology company Nanollose (ASX: NC6) has entered into a collabo...

Nanollose (NC6) pens a collaboration agreement with Paradise Textiles in an aim to create a more sustainable fashion industry Under the agreement, the parties will work together to develop and manufacture yarn and textiles which will inclu...

Nanollose has entered a collaboration with an innovative vegan leather and materials company as interest continues to gain momentum in its eco-friendly microbial cellulose-based technology. Australian-based biomaterial technology company Na...

Nanollose (NC6) is collaborating with material innovation company, von Holzhausen, to create vegan leather from plants and other recycled content As part of the one-year deal, Nanollose will provide samples of treated and processed microbi...

Nanollose completes its first pilot spin of eco-friendly Nullarbor-20 lyocell fibre, signs partnerships and is in strong financial position in milestone quarter. Australian-based biomaterial technology company Nanollose Ltd (ASX: NC6) has...

The Healthcare sector has been struggling as the pandemic wanes But most money managers are still bullish on the sector The biggest movements and news from ASX healthcare stocks this week  Dr Anthony Faucci, America’s top infectious disea...

Biomaterials company Nanollose (NC6) signs an exclusive one-year collaboration agreement with a leading sustainable denim manufacture Under the agreement, the companies will develop denim materials which will include Nanollose’s Nullarbor...

The healthcare sector is experiencing a dry run IPO listings have fallen significantly on weak market appetite  A snapshot of the return of recent ASX Healthcare IPO stocks We are currently in the longest and steepest bear market for biot...

Biotech sector has had a tough time recently But there are signs of things improving this year A look at biotech movers on the ASX in the past fortnight Biotech stocks entered a bear phase in the middle of 2021, and things haven’t improve...

On the Bid is a Stockhead video series featuring a roundtable of experts discussing a new investment topic each week. In this edition, host Oriel Morrison discusses how we can achieve a sustainable future in the world of fashion, the devel...

Telehealth was already a growing space even before the pandemic, but COVID had launched it into the mainstream. At the height of the pandemic in 2020, data from Research and Markets showed that 76% of hospitals in the US were using teleheal...

Biomaterials company Nanollose (NC6) successfully completed its first pilot scale spin of its Nullarbor-20 fibre The spin was completed by Nanollose’s strategic partner, with it demonstrating the capacity for its technology to be integrate...

Nanollose has completed its hugely-anticipated pilot spin of its eco-friendly, sustainable Nullarbor-20 lyocell fibre, and some of the world’s leading fashion houses are lining up to get first touch. Australian-based biomaterial technology...

Nanollose has got a powerful new ally to promote its revolutionary technology converting fermented waste into environmentally friendly fibres.   Australian-based biomaterial technology company Nanollose Ltd (ASX: NC6)’s tree-free rayon fibr...

The ongoing lawsuit involving Johnson & Johnson (J&J)’s talc products took a controversial turn in the courts this week. The healthcare giant is currently staring down 38,000 claims that its talc products (including the famous baby...

The ASX Emerging Companies (XEC) index was climbing at 4pm (Sydney time) up 1.8% and outpacing the S&P/ASX 200 index (XJO), weighed down as it is by a few of those unwieldy iron ore giants after China’s favourite rock fell 9% ‘cos Chine...

Nanollose is on the cusp of a transformative year, with its revolutionary technology that converts fermented waste into environmentally friendly fibres for the fashion textile industry. Australian-based biomaterial technology company Nanol...

At the time of writing, the ASX XHJ Healthcare index is up 5.55% over the last five trading days, beating the ASX200 benchmark index which was up 2.8% for the period. Here’s a table showing how ASX-listed healthcare stocks have been perform...

It’s been a rocky two weeks for small-cap health companies with 42 gaining ground, 76 losing it, and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. CODE COMPANY PRICE 1 WEEK RETURN %...

The life sciences sector has emerged into the spotlight ever since the pandemic began. In the US, the share prices of major vaccine-producing companies have surged astronomically as COVID-19  ravaged the world. Nasdaq-listed BioNTech, which...

It’s been a rocky two weeks for small-cap health companies, with 27 companies gaining ground, 89 losing it and 21 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Name Price % Six Mont...

It’s been a rocky two weeks for small-cap health companies, with 33 companies gaining ground, 86 losing it and 16 flatlining.   Here’s a table showing how ASX-listed healthcare stocks have been performing. Code Company Price % Six M...

The hot debut of Evolution Energy Minerals (ASX:EV1) was not enough to save the ASX resources sector from falling today. The ASX 200 finished 0.67% down at 7,420 points. All sectors were down except tech, which gained 0.18%. In contrast, mo...

The patented process, which uses streams from various large-scale industries, including food and agriculture, can produce ‘tree-free’ cellulose, with obvious environmental benefits.  

The ASX had a positive finish to the week although it is in negative territory for the week. The ASX 200 closed at 7,443 points which is up 0.83% from yesterday but slightly down from the 7,457 mark it closed at last Friday. Today, the only...

Although earnings results were the main theme in August, there were also some notable healthcare breakthroughs on the ASX. Dimerix (ASX:DXB) jumped 45% during the month after announcing the commencement of ACTION 3, a Phase III study in pat...

The biomaterials company is aiming to commence production of its unique tree-free cellulose fibre nullarbor™ in the near-term.

The biotech company recorded a loss of $931,000 in FY21, a 26% improvement on the previous financial year.

It’s been a mixed two weeks for small-cap health companies, with only 45 companies gaining ground, 76 losing it and 23 flatlining. Rhinomed (ASX:RNO) was the biggest gainer, up a massive 85% for the fortnight after scoring a contract with N...

The ASX 200 health stocks index is tracking the broader index well over the past two weeks. Both the XHJ Health Sector and the ASX 200 benchmark rose by 3% over this period. A handful of ASX health stocks have seen their prices skyrocket du...

The company is also working towards shortlisting potential offtake partners and hopes to formalise a number of agreements in the current quarter. 

It’s been a mixed two weeks for small-cap health companies, with only 38 companies gaining ground, 74 losing it and 21 flatlining. Analytica Limited (ASX:ALT) was the biggest gainer, up 25% from 8 to 20 July, followed by  Rhinomed (ASX:RNO)...

It’s been a mixed two weeks for small-cap health companies, with 60 companies gaining ground and 52 losing it – and 21 flatlining. Botanix Pharma Ltd (ASX:BOT) was the biggest gainer, up 38% from 23 June to 7 July, and Suda Pharmaceuticals...

Here’s our fortnightly wrap of all the news driving ASX health stocks. The healthcare sector has returned 2.3 per cent for the last two weeks, compared to the broader market which rose by 2.7 per cent. The biggest news globally was out of U...

This first pilot fibre spin will generate samples for potential partners in the fashion and textiles industries.

Niv Dagan, Peak Asset Management BUY RECOMMENDATIONS Nanollose (NC6) This biomaterials company is commercialising technology to create fibres and fabrics with minimal environmental impact. NC6 has a joint patent application and collaboratio...

Summary Biopharmaceutical company Bionomics Limited will expand its product pipeline for the treatment of Social Anxiety Disorder (SAD). The Company disclosed that the rapid oral absorption of the novel tablet formulation of BNC210 is...

Significant interest has been received for both the 100% tree-free lyocell and various blends, with samples from upcoming pilot spins to be despatched to select brands and preferred partners.

Closing Bell is Stockhead’s daily recap of the ASX’s biggest winners and losers. Data is taken at the market close – at 4.10pm AEDT. Stocks highlighted in yellow rose (or fell) after making announcements during intraday trade. WINNERS Scrol...

The bio-materials company has received strong interest from major international clothing brands and super users of cellulose-based fibres.

Stockhead’s Top 10 at 10, published at 10.15am each trading day, highlights the best (and worst) performing ASX small caps in morning trade using live data. It’s a short, sharp update to help frame the trading day by showing the biggest mov...

The bio-materials company is focused on progressing pilot production to produce sufficient quantities of its lyocell fibre with minimal environmental impact to make commercial agreements with fashion brands.

Nanollose (ASX: NC6) has raised $2,850,000 in an over-subscribed placement to sophisticated and professional investors, with funds to underpin pilot production of its environmentally friendly tree-free fibres and fabrics. Traditional rayon...